...
首页> 外文期刊>Antimicrobial agents and chemotherapy. >In Vitro and In Vivo Activities of Antimicrobials against Nocardia brasiliensis.
【24h】

In Vitro and In Vivo Activities of Antimicrobials against Nocardia brasiliensis.

机译:针对巴西诺卡氏菌的抗菌剂的体外和体内活性。

获取原文
获取原文并翻译 | 示例
           

摘要

In Mexico mycetomas are mostly produced by Nocardia brasiliensis, which can be isolated from about 86% of cases. In the present work, we determined the sensitivities of 30 N. brasiliensis strains isolated from patients with mycetoma to several groups of antimicrobials. As a first screening step we carried out disk diffusion assays with 44 antimicrobials, including aminoglycosides, cephalosporins, penicillins, quinolones, macrolides, and some others. In these assays we observed that some antimicrobials have an effect on more than 66% of the strains: linezolid, amikacin, gentamicin, isepamicin, netilmicin, tobramycin, minocycline, amoxicillin-clavulanic acid, piperacillin-tazobactam, nitroxolin, and spiramycin. Drug activity was confirmed quantitatively by the broth microdilution method. Amoxicillin-clavulanic acid, linezolid, and amikacin, which have been used to treat patients, were tested in an experimental model of mycetoma in BALB/c mice in order to validate the in vitro results. Linezolid showed the highest activity in vivo, followed by the combination amoxicillin-clavulanic acid and amikacin.
机译:在墨西哥,菌丝瘤主要由巴西诺卡氏菌产生,可从约86%的病例中分离出来。在目前的工作中,我们确定了从霉菌病患者中分离出的30株巴西乳杆菌对几类抗生素的敏感性。作为第一步筛选,我们使用44种抗微生物剂进行了磁盘扩散测定,其中包括氨基糖苷类,头孢菌素类,青霉素类,喹诺酮类,大环内酯类和其他一些。在这些测定中,我们观察到某些抗微生物剂对超过66%的菌株有影响:利奈唑胺,阿米卡星,庆大霉素,异帕米星,奈替米星,妥布霉素,米诺环素,阿莫西林-克拉维酸,哌拉西林-他唑巴坦,硝恶唑啉和螺旋霉素。通过肉汤微稀释法定量确认药物活性。为了验证体外结果,在BALB / c小鼠的菌丝瘤实验模型中测试了已用于治疗患者的阿莫西林-克拉维酸,利奈唑胺和丁胺卡那霉素。利奈唑胺在体内的活性最高,其次是阿莫西林-克拉维酸和阿米卡星的组合。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号